Allovir Inc
For the period ended Dec 31, 2023. Filed Mar 15, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 15, 2024
KLRS$2.30-5.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Stockholders’ Equity
| Common Stock · AdditionalPaid-In · AccumulatedOtherComprehensive · Accumulated · TotalStockholders’ | ||||||
|---|---|---|---|---|---|---|
| (in thousands, except share amounts) | Shares | Amount | Capital | (Loss) Income | Deficit | Equity |
| Balance at December 31, 2021 | 63,565,886 | $7 | $522,479 | $(155) | $(297,065) | $225,266 |
| Stock-based compensation | — | — | 41,315 | — | — | 41,315 |
| Issuance of common stock, upon vesting of restricted stock | 1,912,210 | — | — | — | — | — |
| Purchase of common stock under the 2020 Employee Stock Purchase Plan | 157,052 | — | 536 | — | — | 536 |
| Issuance of common stock in registered direct offering, net of $0.2 million issuance costs | 27,458,095 | 2 | 126,423 | — | — | 126,425 |
| Unrealized loss on available-for-sale securities | — | — | — | (313) | — | (313) |
| Net loss | — | — | — | — | (168,710) | (168,710) |
| Balance at December 31, 2022 | 93,093,243 | $9 | $690,753 | $(468) | $(465,775) | $224,519 |
| Stock-based compensation | — | — | 40,779 | — | — | 40,779 |
| Issuance of common stock, upon vesting of restricted stock | 921,505 | — | — | — | — | — |
| Purchase of common stock under the 2020 Employee Stock Purchase Plan | 134,243 | — | 326 | — | — | 326 |
| Issuance of common stock in public offering, net of underwriting discounts, commissions and offering costs | 20,000,000 | 2 | 70,167 | — | — | 70,169 |
| Unrealized gain on available-for-sale securities | — | — | — | 406 | — | 406 |
| Net loss | — | — | — | — | (190,418) | (190,418) |
| Balance at December 31, 2023 | 114,148,991 | $11 | $802,025 | $(62) | $(656,193) | $145,781 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.